![A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer - ScienceDirect A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2090123220300539-ga1.jpg)
A randomized phase II trial of best supportive care with or without hyperthermia and vitamin C for heavily pretreated, advanced, refractory non-small-cell lung cancer - ScienceDirect
![Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression | Scientific Reports Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-29386-7/MediaObjects/41598_2018_29386_Fig1_HTML.png)
Hormetic dose response to L-ascorbic acid as an anti-cancer drug in colorectal cancer cell lines according to SVCT-2 expression | Scientific Reports
![High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02134-y/MediaObjects/13046_2021_2134_Fig6_HTML.png)
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text
![High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02134-y/MediaObjects/13046_2021_2134_Fig2_HTML.png)
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text
![Frontiers | Role of vitamins A, C, D, E in cancer prevention and therapy: therapeutic potentials and mechanisms of action Frontiers | Role of vitamins A, C, D, E in cancer prevention and therapy: therapeutic potentials and mechanisms of action](https://www.frontiersin.org/files/Articles/1281879/fnut-10-1281879-HTML/image_m/fnut-10-1281879-g001.jpg)
Frontiers | Role of vitamins A, C, D, E in cancer prevention and therapy: therapeutic potentials and mechanisms of action
![Vitamin C intake and colorectal cancer survival according to KRAS and BRAF mutation: a prospective study in two US cohorts | British Journal of Cancer Vitamin C intake and colorectal cancer survival according to KRAS and BRAF mutation: a prospective study in two US cohorts | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-023-02452-2/MediaObjects/41416_2023_2452_Fig1_HTML.png)
Vitamin C intake and colorectal cancer survival according to KRAS and BRAF mutation: a prospective study in two US cohorts | British Journal of Cancer
![Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge](https://www.frontiersin.org/files/Articles/391115/fphys-09-01182-HTML/image_m/fphys-09-01182-t001.jpg)
Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
![Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge](https://www.frontiersin.org/files/Articles/391115/fphys-09-01182-HTML/image_m/fphys-09-01182-t004.jpg)
Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
![High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-021-02134-y/MediaObjects/13046_2021_2134_Fig3_HTML.png)
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text
![Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit | New England Journal of Medicine Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit | New England Journal of Medicine](https://content.jwplatform.com/thumbs/jwrqbyMM-720.jpg)
Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit | New England Journal of Medicine
![Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge](https://www.frontiersin.org/files/Articles/391115/fphys-09-01182-HTML/image_m/fphys-09-01182-t005.jpg)
Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
![Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge](https://www.frontiersin.org/files/Articles/391115/fphys-09-01182-HTML/image_m/fphys-09-01182-g001.jpg)
Frontiers | Intravenous Vitamin C for Cancer Therapy – Identifying the Current Gaps in Our Knowledge
![Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression | Scientific Reports Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-018-23714-7/MediaObjects/41598_2018_23714_Fig7_HTML.jpg)
Vitamin C promotes apoptosis in breast cancer cells by increasing TRAIL expression | Scientific Reports
![Nutrients | Free Full-Text | Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue Nutrients | Free Full-Text | Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue](https://pub.mdpi-res.com/nutrients/nutrients-13-01154/article_deploy/html/images/nutrients-13-01154-ag.png?1628009705)
Nutrients | Free Full-Text | Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue
![High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs13046-021-02134-y/MediaObjects/13046_2021_2134_Fig1_HTML.png)
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer | Journal of Experimental & Clinical Cancer Research | Full Text
High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial | PLOS ONE
![Vitamin C and Vitamin D—friends or foes in modulating γδ T-cell differentiation? | Cellular & Molecular Immunology Vitamin C and Vitamin D—friends or foes in modulating γδ T-cell differentiation? | Cellular & Molecular Immunology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41423-022-00895-w/MediaObjects/41423_2022_895_Fig1_HTML.png)